New study refines understanding of long COVID, with naltrexone in focus

A Stanford University news item reports a study refining understanding of long COVID. Other outlets describe a related study examining whether low-dose naltrexone eases symptoms, with MedPage Today saying it is linked to some improvements.

Timeline

1. 29 Oct, 07:39 UTCFirst appeared on Times of India
2. 29 Oct, 15:50 UTCPicked up on Google Trends
3. 29 Oct, 15:50 UTCStanford publishes study on long COVID
4. 29 Oct, 15:50 UTCMedPage Today covers naltrexone link

Top sources

• long covidGoogle Trends
• Common anti-inflammatory drugs may help flu, COVID viruses spread: studyTimes of India
• Study refines our understanding of long COVIDStanford University
• Can Low-Dose Naltrexone Ease Long COVID Symptoms? New Study Examines The EvidenceHealth and Me
• Low-Dose Naltrexone Linked to Some Long COVID ImprovementsMedPage Today